liposom
investig
extens
vaccin
deliveri
system
herein
adjuv
activ
liposom
differ
net
surfac
charg
neutral
posit
neg
evalu
admix
protein
antigen
ovalbumin
ova
pi
bacillu
anthraci
protect
antigen
protein
pa
pi
cation
ova
cova
mice
immun
subcutan
ova
admix
differ
liposom
gener
differ
antibodi
respons
interestingli
ova
admix
net
neg
charg
liposom
prepar
dopa
immunogen
ova
admix
posit
charg
liposom
prepar
dotap
immun
mice
anthrax
pa
protein
admix
net
neg
charg
dopa
liposom
also
induc
strong
function
antipa
antibodi
respons
cation
ova
use
model
antigen
liposom
net
neutral
neg
posit
charg
show
compar
adjuv
activ
immun
mice
ova
admix
dopa
liposom
also
induc
ovaspecif
cytotox
lymphocyt
respons
significantli
delay
growth
ovaexpress
tumor
mice
howev
net
neg
charg
liposom
show
strong
adjuv
activ
adjuv
activ
neg
charg
liposom
may
relat
liposom
abil
upregul
express
molecul
relat
activ
matur
antigenpres
cell
ii
slightli
facilit
uptak
antigen
antigenpres
cell
simpli
admix
certain
neg
charg
liposom
certain
protein
antigen
interest
may
repres
novel
platform
vaccin
develop
new
approach
vaccin
develop
use
recombin
protein
antigen
signific
advantag
tradit
vaccin
consist
live
attenu
pathogen
whole
inactiv
organ
inactiv
toxin
howev
recombin
protein
antigen
alon
often
poorli
immunogen
nonimmunogen
thu
need
potent
vaccin
adjuv
enhanc
result
immun
respons
recent
year
particul
carrier
extens
research
vaccin
deliveri
system
gener
accept
mani
particl
carrier
adjuv
activ
like
due
particl
abil
facilit
uptak
antigen
apc
moreov
enhanc
antigen
stabil
present
multipl
copi
antigen
abil
includ
immunomodul
also
advantag
use
particul
vaccin
deliveri
system
liposom
well
known
lipidbas
particul
vaccin
deliveri
system
adjuv
activ
liposom
first
report
allison
gregoriadi
use
diphtheria
toxoid
antigen
sinc
adjuv
activ
liposom
extens
studi
mani
paramet
may
affect
adjuv
activ
liposom
investig
found
varieti
factor
particl
size
surfac
charg
lipid
composit
method
antigen
load
name
liposomebas
vaccin
formul
potenti
shape
result
immun
respons
antigen
interest
numer
studi
defin
adjuv
activ
neg
posit
charg
liposom
examin
effect
charg
liposom
adjuv
activ
result
rather
conflict
inconclus
exampl
allison
gregoriadi
report
diphtheria
toxoid
neg
charg
liposom
elicit
significantli
higher
antibodi
level
posit
charg
liposom
howev
nakanishi
et
al
report
posit
charg
liposom
contain
protein
antigen
potent
induc
antigenspecif
ctl
respons
neg
charg
neutral
liposom
similarli
afrin
et
al
show
leishmania
donovani
antigen
encapsul
posit
charg
liposom
induc
strongest
level
protect
experiment
viscer
leishmaniasi
mice
follow
neutral
neg
charg
liposom
respect
contrari
anoth
studi
use
recombin
glycoprotein
leishmania
antigen
shown
antigen
entrap
neutral
liposom
confer
significantli
higher
protect
type
immun
respons
antigen
entrap
posit
charg
liposom
wherea
neg
charg
liposom
favor
induct
type
immun
respons
present
studi
adjuv
activ
liposom
differ
net
surfac
charg
ie
neutral
posit
charg
neg
charg
investig
often
protein
antigen
either
entrap
insid
liposom
coval
conjug
onto
surfac
liposom
liposom
use
vaccin
deliveri
system
entrap
protein
antigen
liposom
mani
advantag
exampl
improv
stabil
protein
protect
degrad
inject
use
bsa
model
antigen
show
tryposin
liposom
entrap
bsa
reduc
antibsa
immun
respons
induc
liposom
trypsinizatoin
liposom
surfac
adsorb
bsa
significantli
reduc
antibsa
respons
induc
moreov
thought
liposom
antigen
entrap
insid
act
depot
allow
slow
persist
releas
antigen
similarli
conjug
antigen
onto
liposom
advantag
well
exampl
shown
conjug
lysozym
antigen
onto
neutral
liposom
induc
significantli
stronger
antibodi
respons
entrap
liposom
howev
significantli
conveni
approach
simpli
mix
antigen
interest
preform
liposom
similar
mix
protein
antigen
aluminum
hydroxid
aluminum
phosphat
suspens
use
mani
human
vaccin
use
model
antigen
ova
pa
protein
bacillu
anthraci
pi
valu
respect
adjuv
activ
net
neutral
net
posit
charg
net
neg
charg
liposom
evalu
simpli
mix
antigen
liposom
inject
mice
found
net
neg
charg
liposom
prepar
certain
neg
charg
lipid
potent
adjuv
activ
admix
protein
antigen
cultur
medium
fb
antibiot
invitrogen
cell
mous
dc
line
grown
rpmi
medium
supplement
fb
uml
penicillin
streptomycin
ovaexpress
cell
kindli
provid
dr
edith
lord
dr
john
freling
univers
rochest
medic
center
rochest
ny
grown
rpmi
medium
fb
geneticin
cell
mous
macrophag
grown
dmem
medium
supplement
fb
uml
penicillin
streptomycin
bmdc
femal
mice
astart
biolog
redmond
wa
grown
dmem
high
glucos
medium
fb
uml
penicillin
streptomycin
liposom
prepar
use
thin
film
hydrat
method
briefli
thin
film
net
neutral
phospholipid
dopc
chol
molar
ratio
mg
total
lipid
form
bottom
glass
scintil
vial
chloroform
evapor
lipid
thin
film
hydrat
dispers
ml
pb
mm
ph
vigor
mix
room
temperatur
result
liposom
extrud
nm
filter
sequenti
use
miniextrud
avanti
polar
lipid
inc
prepar
net
posit
neg
charg
liposom
dopc
replac
dotap
dopa
respect
prepar
differ
neg
charg
liposom
dop
dopg
dcp
use
follow
dop
chol
mm
dopg
dopc
chol
mmm
dcp
dopc
chol
mmm
mg
total
lipid
endotoxin
level
liposom
prepar
measur
liposom
prepar
dotap
dopa
dopg
estim
euml
use
chromogen
lal
endotoxin
assay
kit
genscript
piscataway
nj
equal
volum
liposom
protein
solut
ova
pa
pb
mm
ph
mix
mixtur
vortex
incub
room
temperatur
least
min
prior
use
cation
ova
cova
prepar
previous
describ
briefli
mg
ova
dissolv
ml
pb
hmd
ml
ph
edc
mg
ad
mixtur
stir
room
temperatur
h
reaction
stop
ad
ml
glycin
solut
follow
anoth
h
stir
cova
purifi
use
column
ge
healthcar
bioscienc
corp
piscataway
nj
concentr
use
ultracentrifug
filter
tube
kda
cutoff
millipor
billerica
protein
concentr
determin
use
bradford
reagent
sigmaaldrich
covaliposom
mixtur
prepar
describ
particl
size
liposom
liposomeprotein
mixtur
determin
use
coulter
plu
submicron
particl
sizer
beckman
coulter
inc
fullerton
ca
turbid
determin
measur
absorb
nm
use
biotek
ht
multimod
micropl
reader
biotek
instrument
inc
winooski
vt
percent
protein
associ
liposom
determin
ultracentrifug
briefli
antigenliposom
mixtur
centrifug
g
h
use
beckmancoult
tlx
benchtop
ultracentrifug
brea
ca
protein
content
supernat
determin
use
cbqca
protein
quantit
kit
molecular
probe
inc
eugen
amount
protein
associ
liposom
deriv
subtract
amount
protein
supernat
total
amount
protein
ad
sucros
gradient
centrifug
use
proteindotap
liposom
mixtur
mixtur
precipit
simpl
centrifug
sucros
gradient
prepar
follow
layer
sucros
ml
proteindotap
liposom
mixtur
ml
sucros
ml
sucros
ml
h
centrifug
g
ml
fraction
total
collect
protein
concentr
fraction
quantifi
use
cbqca
kit
liposomeassoci
protein
peak
fraction
protein
alon
peak
fraction
protein
associ
liposom
calcul
use
trapezoid
rule
experi
repeat
least
time
anim
studi
carri
follow
nation
institut
health
guidelin
anim
care
use
anim
protocol
approv
institut
anim
care
use
committe
univers
texa
austin
oregon
state
univers
femal
balbc
mice
week
age
simonsen
laboratori
inc
gilroy
ca
charl
river
laboratori
wilmington
vaccin
formul
administr
subcutan
sc
inject
everi
two
week
three
time
ovaliposom
mixtur
ovamouseinject
two
time
paliposom
mixtur
pamouseinject
covaliposom
mixtur
covamous
inject
protein
admix
alum
pa
mouseinject
usp
grade
spectrum
chemic
laboratori
product
cardena
ca
use
posit
control
mice
neg
control
group
inject
steril
pb
two
week
last
inject
mice
euthan
collect
blood
antigenspecif
igg
level
determin
use
elisa
briefli
polystyren
medium
bind
plate
bd
bioscienc
coat
ng
ova
cova
pa
carbon
buffer
ph
overnight
antiova
anticova
antibodi
determin
plate
wash
pbstween
mm
ph
tween
block
block
solut
hors
serum
pb
tween
vv
h
serum
sampl
dilut
time
twofold
serial
titer
block
solut
ad
plate
follow
remov
block
solut
h
incub
sampl
remov
plate
wash
five
time
pbstween
horseradish
peroxidaseconjug
goat
antimous
immunoglobulin
igg
dilut
hors
serum
pbstween
vv
ad
plate
follow
anoth
hour
incub
plate
wash
five
time
pb
tween
min
incub
room
temperatur
tmb
solut
follow
addit
stop
solut
n
sulfur
acid
presenc
bound
specif
antibodi
detect
nm
antipa
antibodi
determin
similarli
except
hors
serum
pbstween
replac
bsa
pbstween
specif
antibodi
respons
report
valu
antibodi
titer
antibodi
titer
determin
consid
absorb
valu
higher
mean
mean
neg
control
group
posit
total
igg
measur
balbc
mice
igg
subtyp
measur
balbc
mice
lethal
toxin
neutral
activ
determin
previous
describ
briefli
confluent
cell
seed
cellswel
steril
clearbottom
plate
incub
overnight
co
fresh
medium
contain
pa
ngml
lethal
factor
ngml
mix
equal
volum
dilut
serum
sampl
incub
h
cell
cultur
medium
remov
serumleth
toxin
mixtur
ad
well
final
concentr
ngml
pa
ng
ml
lethal
factor
cell
incub
h
co
cell
viabil
determin
use
mtt
assay
untreat
lethal
toxin
alon
treat
cell
control
vivo
ctl
assay
carri
previous
describ
femal
mice
immun
ovadopa
liposom
complex
ovamous
day
ova
adjuv
ifa
sigmaaldrich
steril
pb
use
posit
neg
control
respect
day
splenocyt
mice
harvest
label
siinfekl
follow
label
high
concentr
cfse
cfse
high
splenocyt
without
siinfekl
label
label
low
concentr
cfse
cfse
low
ten
million
cell
popul
mix
inject
intraven
via
tail
vein
immun
mice
three
h
inject
mice
euthan
rel
abund
cfse
high
cfse
low
cell
splenocyt
prepar
determin
use
flow
cytomet
beckman
coulter
epic
v
dual
laser
flow
cytomet
fullerton
ca
tumor
prevent
studi
day
first
immun
cell
subcutan
inject
flank
mice
n
tumor
size
measur
use
calip
report
base
follow
equat
tumor
size
mm
width
length
mice
euthan
day
tumor
cell
inject
blood
collect
liposom
mix
fitclabel
ova
fitcova
prepar
follow
manufactur
instruct
sigmaaldrich
cell
cellswel
seed
plate
allow
grow
overnight
cell
incub
fitcovaliposom
mixtur
h
co
incub
cell
wash
three
time
cold
pb
lyse
lysi
buffer
triton
centrifug
g
collect
supernat
fluoresc
intens
supernat
measur
use
biotek
ht
multimod
micropl
reader
control
cell
incub
fitcova
alon
fresh
medium
alon
cell
cellswel
seed
sixwel
plate
overnight
incub
cell
incub
dotap
liposom
dopa
liposom
ova
solut
ova
co
cell
also
treat
steril
pb
neg
control
lp
e
coli
ng
sigma
posit
control
h
cell
wash
twice
stain
buffer
fb
nan
pb
stain
fitclabel
antibodi
pelabel
antiia
b
mhc
ii
min
wash
twice
analyz
facscalibur
flow
cytomet
bd
bioscienc
cell
cellswel
seed
sixwel
plate
overnight
incub
cell
incub
dopa
liposom
steril
pb
h
co
total
rna
extract
use
rneasi
mini
kit
qiagen
valencia
ca
accord
manufactur
instruct
one
total
rna
use
synthes
cdna
use
rt
first
strand
kit
dilut
first
strand
cdna
use
prepar
experiment
cocktail
rt
sybr
qpcr
master
mix
dilut
cdna
nucleasefre
water
twentyf
experiment
cocktail
ad
well
pcr
array
realtim
pcr
perform
use
abi
appli
biosystem
inc
foster
citi
ca
plate
incub
min
cycl
time
min
c
valu
obtain
sd
softwar
appli
biosystem
use
calcul
fold
chang
gene
express
webbas
pcr
array
data
analysi
softwar
sabiosci
total
rna
isol
cell
treat
dopa
liposom
pb
h
describ
twostep
rtpcr
perform
one
total
rna
use
synthes
cdna
use
iii
firststrand
synthesi
supermix
qrtpcr
invitrogen
primer
pair
mous
forward
revers
forward
revers
forward
revers
synthes
idt
technolog
coralvil
ia
cdna
use
pcr
reaction
mixtur
includ
templat
dna
primer
taq
dna
polymeras
mixtur
incub
min
cycl
time
time
min
min
use
eppendorf
mastercycl
hauppaug
ny
pcr
product
analyz
use
agros
gel
electrophoresi
band
intens
measur
use
syngen
gbox
genesnap
softwar
syngen
il
cell
cellswel
seed
sixwel
plate
overnight
incub
cell
incub
dopa
liposom
dop
liposom
co
control
cell
also
treat
steril
pb
lp
ng
dotap
liposom
dopc
liposom
h
incub
supernat
collect
analyz
use
mous
elisa
kit
r
system
minneapoli
mn
mous
elisa
kit
bd
bioscienc
respect
bmdc
cellswel
seed
twelvewel
plate
incub
overnight
cell
stimul
dopa
liposom
dop
liposom
h
pb
lp
ng
use
control
product
supernat
determin
statist
analys
complet
use
anova
follow
fisher
protect
least
signific
differ
procedur
pvalu
twotail
consid
statist
signific
net
neutral
posit
charg
neg
charg
liposom
prepar
use
dopc
dotap
dopa
respect
mean
size
neutral
posit
charg
neg
charg
liposom
nm
respect
ovaliposom
mixtur
prepar
simpli
mix
equal
volum
liposom
differ
concentr
ova
solut
eg
shown
fig
signific
aggreg
form
posit
charg
liposom
dotap
mix
high
concentr
ova
indic
increas
turbid
mixtur
fig
concentr
less
turbid
mixtur
slightli
differ
liposom
alon
therefor
ovaliposom
mixtur
contain
ova
use
immun
studi
particl
size
liposom
ovaliposom
mixtur
final
ova
concentr
differ
neutral
dopc
net
neg
dopa
charg
liposom
wherea
size
ovadotap
liposom
mixtur
significantli
larger
dotap
liposom
alon
fig
final
percentag
ova
associ
net
neutral
posit
neg
charg
liposom
estim
respect
evalu
compar
adjuv
activ
liposom
differ
net
charg
mice
immun
ova
admix
dopc
dotap
dopa
liposom
expect
ovadotap
liposom
mixtur
induc
strong
antiova
igg
respons
fig
ovaneg
charg
dopa
liposom
mixtur
induc
antiova
igg
respons
strong
induc
ovadotap
liposom
mixtur
fig
ovadopc
liposom
mixtur
weakli
immunogen
fig
antiova
antibodi
respons
bias
ovadotap
liposom
mixtur
ovadopa
liposom
mixtur
induc
strong
antiova
respons
fig
wherea
signific
level
antiova
detect
serum
immun
mice
fig
fig
antiova
igg
respons
induc
ova
pb
ova
admix
dopa
liposom
compar
confirm
strong
ovaspecif
antibodi
respons
observ
simpli
due
ova
protein
alon
pa
protein
use
antigen
padopa
liposom
mixtur
induc
antipa
igg
respons
significantli
stronger
induc
pa
adjuv
alum
fig
paneutr
dopc
liposom
mixtur
induc
antipa
igg
respons
similar
induc
pa
adjuv
alum
antipa
igg
level
mice
immun
padopc
liposom
mixtur
pa
adjuv
alum
differ
mice
inject
steril
pb
dilut
fig
antipa
antibodi
induc
paliposom
mixtur
function
antisera
abl
neutral
anthrax
lethal
toxin
protect
mous
macrophag
lethal
toxin
challeng
fig
three
liposom
formul
pa
admix
alum
induc
strong
antipa
respons
fig
antipa
detect
serum
sampl
mice
treat
pa
admix
dotap
liposom
dopa
liposom
mice
treat
pa
admix
dopc
liposom
alum
fig
fig
antipa
igg
respons
induc
pa
pb
compar
induc
pa
admix
alum
pi
ova
cation
ova
cova
migrat
opposit
direct
appli
agros
gel
trisbor
acid
buffer
ph
data
shown
demonstr
success
cation
ova
expect
neg
charg
dopa
liposom
mix
high
concentr
cova
signific
aggreg
form
shown
increas
turbid
fig
wherea
aggreg
observ
cova
mix
posit
charg
dotap
liposom
neutral
dopc
liposom
fig
cova
pb
mix
liposom
particl
size
liposom
covaliposom
mixtur
significantli
differ
fig
therefor
formul
contain
cova
use
immun
mice
interestingli
cova
admix
three
differ
liposom
induc
compar
level
anticova
igg
respons
fig
cova
strongli
immunogen
fig
although
inclus
alum
adjuv
still
help
significantli
evalu
adjuv
activ
differ
neg
charg
liposom
ova
admix
liposom
prepar
differ
neg
charg
lipid
dop
dopg
dcp
use
immun
mice
fig
size
liposom
prepar
differ
neg
charg
lipid
differ
p
anova
fig
liposom
size
liposom
correspond
ova
liposom
mixtur
significantli
differ
fig
antiova
igg
titer
serum
sampl
mice
immun
ova
admix
dopa
liposom
dop
liposom
dcp
liposom
strong
wherea
ovadopg
liposom
mixtur
seem
weakli
immunogen
fig
mice
immun
ova
admix
dopa
liposom
ova
adjuv
ifa
subcutan
inject
ovaexpress
tumor
cell
growth
tumor
monitor
tumor
becam
visibl
day
inject
grew
continu
unimmun
mice
fig
contrast
tumor
grew
slowli
mice
immun
ova
admix
dopa
liposom
fig
immun
mice
tumorfre
end
studi
tumor
grow
mice
immun
ova
adjuv
ifa
granuloma
visibl
inject
site
antiova
igg
titer
shown
fig
serum
sampl
mice
day
tumor
cell
inject
antiova
igg
titer
mice
immun
ova
adjuv
ifa
significantli
higher
mice
immun
ova
admix
dopa
liposom
character
immun
respons
induc
ovadopa
liposom
mixtur
ovaspecif
ctl
respons
induc
measur
use
vivo
ctl
assay
shown
fig
ctl
respons
lytic
activ
detect
mice
immun
ova
admix
dopa
liposom
lytic
activ
detect
mice
immun
ova
adjuv
ifa
separ
experi
ova
siinfkel
specif
vivo
ctl
activ
mice
immun
ovadopa
liposom
mixtur
compar
mice
immun
ova
admix
alum
ova
adjuv
ifa
ova
adjuv
ifa
induc
strongest
ctl
activ
follow
ova
admix
dopa
liposom
averag
weak
ctl
activ
detect
mice
immun
ova
admix
alum
ova
alon
steril
pb
data
shown
fitclabel
ova
admix
liposom
differ
net
charg
incub
cell
shown
fig
dopa
liposom
slightli
facilit
uptak
ova
cell
far
less
dotap
liposom
neutral
dopc
liposom
significantli
affect
uptak
ova
cell
fig
dopa
liposom
significantli
upregul
express
mhc
ii
molecul
cell
fig
detect
effect
express
fig
even
increas
concentr
dopa
liposom
data
shown
dotap
liposom
contrast
slightli
upregul
mhc
ii
cell
fig
realtim
pcr
reveal
differenti
express
gene
relat
dc
apc
activ
matur
cell
stimul
dopa
liposom
cytokin
chemokin
receptor
ii
antigen
uptak
iii
antigen
present
iv
cell
surfac
receptor
v
signal
transduct
relb
fig
overexpress
mrna
confirm
semiquantit
rtpcr
fig
c
elisa
assay
also
confirm
upregul
express
cell
stimul
neg
charg
dopa
dop
liposom
although
level
cell
stimul
dopa
liposom
differ
cell
treat
steril
pb
fig
e
incub
posit
charg
dotap
liposom
net
neutral
dopc
liposom
significantli
upregul
secret
cell
fig
e
final
dopa
dop
liposom
upregul
express
mous
bmdc
well
fig
confirm
find
cell
present
studi
show
protein
antigen
admix
certain
net
neg
charg
liposom
prepar
neg
charg
dopa
lipid
induc
strong
function
antibodi
respons
subcutan
inject
mice
antibodi
respons
bias
immun
antigen
admix
neg
charg
liposom
also
induc
antigenspecif
ctl
respons
prevent
growth
antigenexpress
tumor
cell
mice
adjuvant
neg
charg
liposom
like
relat
abil
regul
express
gene
relat
dc
activ
matur
ii
slightli
facilit
uptak
antigen
apc
interest
find
simpli
admix
protein
antigen
net
neg
charg
liposom
prepar
certain
neg
charg
lipid
dopa
show
potent
adjuv
activ
cell
cultur
neg
charg
dopa
liposom
slightli
enhanc
uptak
ova
protein
model
antigen
mous
cell
significantli
less
effect
posit
charg
liposom
prepar
use
dotap
lipid
fig
neg
charg
dopa
liposom
posit
charg
dotap
liposom
show
strong
adjuv
activ
fig
therefor
mechan
abil
enhanc
antigen
uptak
like
contribut
adjuv
activ
neg
charg
dopa
liposom
simpli
admix
antigen
dopa
liposom
also
significantli
upregul
express
gene
relat
dc
activ
matur
fig
exampl
dopa
liposom
upregul
express
mhc
ii
compon
mhc
molecul
relat
antigen
present
apc
dopa
liposom
dop
liposom
also
significantli
upregul
express
chemokin
ccl
fig
known
immatur
dc
produc
inflammatori
chemokin
includ
matur
dc
lose
abil
produc
inflammatori
chemokin
switch
produc
chemokin
attract
b
lymphocyt
specul
abil
certain
neg
charg
liposom
induc
dc
activ
matur
may
explain
adjuv
activ
final
preliminari
observ
posit
charg
dotap
liposom
net
neutral
dopc
liposom
fail
significantli
upregul
secret
cell
suggest
mechan
adjuv
activ
differ
charg
liposom
like
differ
fig
show
neg
charg
liposom
strong
adjuv
activ
exampl
neg
charg
liposom
prepar
dopa
dop
dcp
shown
compar
strong
adjuv
activ
admix
ova
net
neg
charg
liposom
prepar
dopg
lipid
show
weak
adjuv
activ
fig
unlik
size
ovaliposom
mixtur
relat
differ
adjuv
activ
four
differ
neg
charg
liposom
size
dopa
dop
dopg
liposom
admix
ova
around
nm
wherea
size
dcp
liposomeova
admixtur
around
nm
experi
need
complet
understand
certain
neg
charg
liposom
strong
adjuv
activ
other
ovadopa
liposom
mixtur
induc
stronger
ovaspecif
antibodi
respons
ova
admix
alum
fig
similarli
padopa
liposom
mixtur
also
induc
stronger
paspecif
antibodi
respons
pa
admix
alum
fig
purpos
use
pa
antigen
twofold
firstli
allow
us
confirm
adjuv
activ
neg
charg
liposom
prepar
dopa
limit
ova
antigen
secondli
use
pa
allow
us
evalu
neutral
activ
specif
antibodi
induc
anthrax
toxinmedi
diseas
b
anthraci
produc
two
toxin
lethal
toxin
edema
toxin
lethal
toxin
compris
pa
protein
anthrax
lethal
factor
edema
toxin
made
pa
edema
factor
pa
protein
requir
entranc
lethal
factor
edema
factor
cell
insid
cell
lethal
factor
edema
factor
toxic
therefor
neutral
antipa
antibodi
show
abl
effect
protect
anthrax
infect
anthrax
toxin
shown
fig
antipa
antibodi
induc
padopa
liposom
mixtur
function
final
seem
neg
charg
liposom
prepar
dopa
help
improv
antibodi
respons
also
cellular
respons
protein
antigen
ovadopa
liposom
mixtur
induc
ovaspecif
ctl
respons
immun
mice
ova
admix
dopa
liposom
prevent
growth
ovaexpress
tumor
cell
mice
fig
three
antigen
use
present
studi
ova
amino
acid
protein
molecul
weight
kda
pi
valu
pa
contain
amino
acid
molecular
weight
kda
pi
therefor
ph
ova
pa
predomin
net
neg
charg
order
understand
adjuv
activ
neg
charg
dopa
liposom
antigen
pi
valu
larger
use
ova
cation
ad
hexamethylen
diamin
gener
cova
protein
data
fig
show
covadopa
liposom
mixtur
also
induc
strong
anticova
igg
respons
agreement
previou
find
catioin
protein
immunogen
origin
protein
cova
strongli
immunogen
may
explain
covadopa
liposom
mixtur
covadotap
liposom
mixtur
covadopc
liposom
mixtur
strongli
immunogen
fig
physiolog
ph
ova
pa
expect
mainli
neg
charg
wherea
cova
expect
mainli
posit
charg
explain
find
ova
found
bind
posit
charg
dotap
liposom
pb
ph
although
less
extent
bind
ova
neg
charg
dopa
liposom
net
neutral
dopc
liposom
also
detect
possibl
due
interact
electrostat
interact
also
explain
increas
turbid
larg
amount
cova
admix
neg
charg
dopa
liposom
dotap
liposom
fig
mention
adjuv
activ
neg
charg
liposom
may
relat
liposom
abil
upregul
express
molecul
relat
activ
matur
apc
ii
facilit
uptak
antigen
apc
howev
antigen
pi
valu
larger
smaller
use
ie
cova
vs
ova
extent
antigen
strongli
bound
neg
charg
liposom
expect
differ
therefor
extent
adjuv
activ
neg
charg
liposom
attribut
abil
facilit
antigen
uptak
apc
may
vari
depend
antigen
use
reason
may
appli
net
posit
charg
liposom
final
net
neutral
dopc
liposom
use
antigen
pa
cova
abl
induc
specif
antibodi
respons
fig
therefor
mechan
adjuvant
liposom
differ
net
charg
like
differ
mention
earlier
liposom
use
antigenvaccin
deliveri
system
often
antigen
interest
entrap
liposom
coval
conjug
onto
surfac
liposom
except
complex
plasmid
dna
posit
charg
liposom
rare
immun
carri
use
antigen
simpli
admix
preform
liposom
simpl
admixtur
antigen
preform
liposom
conveni
commerci
favor
avoid
procedur
entrap
antigen
liposom
chemic
conjug
antigen
onto
surfac
liposom
base
find
present
studi
neg
charg
dopa
liposom
potent
alum
increas
immunogen
ova
pa
antigen
ova
admix
neg
charg
dopa
liposom
also
induc
specif
ctl
respons
conclud
neg
charg
liposom
may
potenti
becom
suitabl
altern
alum
admix
certain
antigen
vaccin
develop
advantag
use
neg
charg
liposom
instead
alum
may
includ
possibl
combin
variou
antigen
type
recombin
protein
live
attenu
virus
singl
deliveri
system
ii
faster
clearanc
neg
charg
liposom
alum
inject
site
howev
prematur
gener
protein
antigen
simpli
admix
neg
charg
liposom
induc
strong
immun
respons
three
antigen
ova
pa
cova
evalu
present
studi
neg
charg
liposom
prepar
dopg
show
potent
adjuv
activ
admix
ova
fig
moreov
data
earli
report
show
simpli
mix
bsa
model
antigen
neg
charg
liposom
prepar
egg
lecithin
chol
phosphatid
acid
fail
induc
antibsa
immun
respons
nonetheless
interest
three
antigen
test
present
studi
abl
induc
strong
specif
antibodi
respons
simpli
admix
net
neg
charg
dopa
liposom
conclus
show
liposom
differ
net
charg
differ
adjuv
activ
depend
antigen
use
certain
net
neg
charg
liposom
show
potent
adjuv
activ
simpli
admix
antigen
interest
neg
charg
liposom
promot
antibodi
cellular
immun
respons
strong
adjuv
activ
neg
charg
liposom
may
attribut
abil
induc
activ
matur
apc
simpli
admix
certain
neg
charg
liposom
certain
antigen
interest
may
repres
novel
conveni
strategi
vaccin
develop
